Amy Mahery
Förmögenhet: 6 $ per 2026-08-31
Förmögenhet: 6 $ per 2026-08-31
Amy Mahery is currently an Independent Director at CNS Pharmaceuticals, Inc. since 2024.
Formerly, Ms. Mahery was Chief Commercial Officer at Roivant Sciences Ltd. from 2022 to 2024 and Senior Vice President at EMD Serono, Inc. from 2021 to 2022.
Ms. Mahery completed undergraduate education at Trinity College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-20 | 1 ( 0 % ) | 6 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2024-01-18 |
| Företag | Position | Slut |
|---|---|---|
| ROIVANT SCIENCES LTD. | Företagsledare/Principal | 2024-12-01 |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Företagsledare/Principal | 2022-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Trinity College
Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån